Supported by an educational grant from Solventum, Medical Surgical Business.<br><br>Learning Objectives:<br>•Review the evolution of NPWT and the latest innovations <br> •Differentiate between various NPWT technologies and apply an algorithmic approach to selecting the appropriate technology based on wound characteristics, patient needs and care setting transitions<br> •Explore the science and clinical application of novel peel and place dressings, determining which wound types are most appropriate for this technology<br> •Apply new therapy application tips toward the use of NPWT with instillation, incision management, and hybrid drapes<br> •Describe the transition of care for NPWT from the acute to the post-acute setting, emphasizing how portable technology can facilitate this <br> •Examine case-based scenarios highlighting the components of the NPWT toolkit, and demonstrate the step-down therapies involved in progressing toward wound closure<br>

The Thomas K. Hunt Endowed Lecture, established in 2013, honors the legacy of Dr. Thomas K. Hunt, a pioneering leader in wound healing research and a founding member of the Wound Healing Society. This annual lecture aims to inspire and educate wound healing researchers by highlighting innovations in related fields. <br><br>Each year, the Wound Healing Foundation selects an honorary speaker, not limited to those directly involved in wound healing research but inclusive of investigators who demonstrate the ability to bridge scientific gaps and apply fundamental physiological principles to understand healing processes across multiple organ systems.<br><br> This year, the Thomas K. Hunt Lecturer will be a distinguished stem cell biologist Dr. Fiona Watt. Dr. Watt, obtained her DPhil from the University of Oxford and completed her postdoctoral research at M.I.T., Cambridge, USA. She established her first laboratory at the Kennedy Institute of Rheumatology in London before moving to the London Research Institute. From 2006 to 2012, she served as Deputy Director of the Cancer Research UK Cambridge Research Institute and the Welcome Trust Centre for Stem Cell Research at the University of Cambridge. <br><br>In September 2012, she joined King’s College London as the Director of the Centre for Stem Cells and Regenerative Medicine. In 2021, the Centre for Stem Cells & Regenerative Medicine (CSCRM) merged with the Centre for Cell and Gene Therapy to form the Centre for Gene Therapy and Regenerative Medicine. <br><br>Dr. Watt's research focuses on cell fate decisions and the skin microenvironment, with current projects exploring self-renewal and lineage selection by human and mouse epidermal stem cells, the role of stem cells in tumor formation in the epidermis and oral tissues, and the assembly and function of the epidermal cornified envelope. <br><br>
In 2022, Dr. Watt became the Director of the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, where she continues to lead a research group focused on these critical areas of study.

Collaborating With Innate Immunity to Treat Antibiotic- Resistant Bacterial Infections <br>
Victor Nizet, PhD <br><br>

Harnessing Commensal Microbes for Skin Repair and Wound Healing<br>
Elizabeth Grice, PhD <br><br>

This session will explore the intricate and evolving interactions between the human host and microbial pathogens, emphasizing the molecular and cellular mechanisms that drive this interaction. Two leading experts will dissect the dynamic relationship between the immune system and pathogens, highlighting how this interaction influences health, disease progression, and recovery, shedding light on potential therapeutic targets for infectious diseases and chronic wounds.

Burn Wound Immunology Explored in Developing Ex Vivo and In Vitro Wound Models<br>
Esther Middelkoop, PhD <br><br>

Cutaneous Sensory Neurons Control Immune and Keratinocyte Function<br>
Daniel Kaplan, PhD<br><br>

This session will focus on the immune system's role in tissue repair, providing a deep dive into the cellular and molecular mechanisms that drive these processes. One speaker will talk about the interactions between innate and adaptive immune cells during wound healing, discussing how these cells coordinate tissue repair and how aberrant immune responses contribute to chronic wound pathology. He will also provide insights into emerging therapeutic targets to restore immune balance and enhance healing outcomes. The other speaker will discuss how innovative biomaterials are being developed to influence immune responses and improve wound healing. Her talk will focus on how these materials can modulate immune activity, offering new therapeutic avenues to support effective tissue repair and prevent complications in chronic wound.

Identifying Reparative Vascular Precursors in Cutaneous Wound Healing <br>
Mervin C. Yoder, PhD<br>
Georgios Theocharidis, PhD<br><br>

This session will discuss the molecular landscape of the injury site at unprecedented resolution by using spatial omics to pinpoint the active genes and how proteins interact in the intricate wound microenvironment. A key focus will be on the diversity and heterogeneity of different residents as well as blood-borne cell types. We will have two top speakers in regenerative medicine talking about the most recent progressions and practical uses in the field and exploring how spatial omics could revolutionize wound care and regenerative medicine potentials. These insights will drive personalized medicine breakthroughs, uncover fresh biomarkers, and guide targeted therapeutic strategies.

Sponsored by EnColl Corporation <br><br>
Chronic skin wounds are resulted from varied conditions such as diabetes, venous insufficiency, physical pressure, or neural impairment. Despite advances in wound care, the molecular mechanisms driving chronic wound healing remain insufficiently understood. This innovation theatre aims to delve into the significance of most biocompatible matrix for the best clinical outcome. Further, the objective is to explore the intricate molecular pathways that influence the healing process in chronic skin wounds, focusing on the roles of inflammation, cellular signaling, and tissue regeneration. The role of collagen phosphorylation in cell signalling is one of the key physiological event yet to be understood and will be explored in depth. By expanding our understanding of these pathways, we aim to uncover novel therapeutic targets and intervention strategies that can accelerate wound healing, enhance tissue regeneration, and improve patient outcomes. Attendees will gain insights into cutting-edge research, technological advancements, and clinical applications, fostering collaboration and driving innovation in the treatment of chronic skin wounds.

The competition focuses on the latest innovations in advanced wound care. The judging criteria for the competition includes novelty of the innovation, development stage, clinical unmet need, market potential, pricing and reimbursement strategy, competitive advantage and competition, and the ability to attract an angel or VC investment. The best wound care innovation for the year will be selected. This session is a WHS Members Only Event and lunch will be provided.<br>

Supported by ProDev Labs; Smith & Nephew; and Team Technologies.

Supported by an educational grant from MiMedx Group, Inc.<br><br> Learning Objectives:<br> •Employ a comprehensive chronic wound workup, including vascular assessment, to identify underlying factors and develop an individualized treatment plan to optimize healing outcomes<br> •Recognize the importance of early and effective debridement to optimize healing outcomes and to maximize the effectiveness of advanced therapies<br> •Explain the science of advanced therapies including CAMPS and advanced bovine collagen matrix and determine when to initiate<br> •Examine the implications of the new LCDs for reimbursement of CAMPs for diabetic foot ulcers and venous leg ulcers<br> •Explore case studies that illustrate the use of CAMPS and advanced bovine collagen matrix, highlighting their impact on clinical outcomes<br>

Unlocking Healing Potential From Bedside to Bench: How can We Reverse the Fortune of Chronic Wounds?<br>
Marjana Tomic-Canic, PhD<br><br>
Inflammation in Chronic Wounds: Mechanisms and Potential Therapeutic Targets<br>
Kenneth W. Liechty, MD<br><br>
This session will explore innovative strategies to enable tissue regeneration and improve outcomes in chronic wounds. Expert speakers will discuss cutting-edge research on the molecular and cellular mechanisms that can be harnessed to "jumpstart" regenerative processes in damaged tissues.

Collective Migration of Epithelial Tissues in Electric Fields<br>
Min Zhao, MD, PhD <br><br>
This session will explore how biophysical principles govern tissue repair and renewal. Two renowned experts will present their research on how mechanical, electrical, and molecular signals converge to promote healing and regeneration. They will focus on the interplay between cellular dynamics and tissue architecture, providing insights into the complex systems that guide tissue renewal in both natural and engineered environments.

Wound Fluid Metabolomics: Footprint of Wound Tissue Metabolism Necessary for Healing<br>
Sashwati Roy, PhD<br><br>

Discarded Wound Dressings: What Does Your Wound Exudate say About You?<br>
Ivan Jozic, PhD<br><br>
This session will explore the role of metabolomics in uncovering the biochemical landscapes that shape wound healing. Two eminent speakers will discuss how metabolic profiling can reveal biomarkers, identify potential therapeutic targets, and offer insights into personalized approaches for wound management. Discussions will include cutting-edge research and the translational potential of metabolomics in clinical wound care.

Sponsored by Smith+Nephew. <br><br>

Objectives: <br>

-Debate the importance of managing the underlying conditions for DFU and VLU <br>

-Analyze the benefits of CAMPs in improving wound healing <br>

-Review DFU /VLU case studies <br>

-Discuss the need for a multidisciplinary plan of care <br><br>

Diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs) represent significant clinical challenges, with multifactorial etiologies requiring a targeted and comprehensive approach to therapy. Both conditions are associated with severe morbidity, including a high rate of amputations, and greatly reduce patients' quality of life. Despite numerous treatments, both systemic and local, the need for innovative therapies remains critical. This 90-minute innovation dinner program will focus on the evolving role of cellular, acellular and matrix-like products (CAMPs) in the treatment of DFUs and VLUs. Through a review of the latest published evidence, the effectiveness of CAMPs will be debated, exploring their potential as a therapeutic option in wound care.

Registered WHS members are invited to attend. Kick off the 2025 WHS Annual Meeting by joining your fellow WHS Members and guests for a night of food, drinks, and fun at the Gaylord Hotel Riverwalk Cantina & Terrace. Registered WHS members are invited to attend. Pre-registration is required. Please head over to the WHS Membership Booth for more details.

Supported by an educational grant from Organogenesis Inc.<br><br>Learning objectives: <br>• Analyze the results of a multicenter study examining the percentage change in venous leg ulcer area as a prognostic index for healing at 24 weeks and evaluate the clinical significance of these findings in predicting long-term healing outcomes and guiding treatment strategies.<br>• Identify wounds at risk of prolonged healing to facilitate timely communication and appropriate treatment interventions.<br>• Recognize the importance of prognostic markers in chronic wound healing and determine when to initiate advanced therapies.<br>• Quantify wound healing progress using predictive values from initial wound assessments, including factors such as wound size, depth, tissue type, and patient-specific variables, to accurately forecast healing outcomes and guide treatment decisions.<br>

Sponsored by ConvaTec. <br><br>

Although underlying patient comorbidities may present obstacles to wound healing, it is increasingly acknowledged that most hard-to-heal wounds contain biofilm, which presents a significant barrier to healing. Overcoming the barrier presented by biofilm should be a key focus in managing and ultimately healing these complex wounds. <br><br>

This session will provide an overview of biofilm in the context of complex wounds, followed by a clinical case-based approach demonstrating the use of an advanced antimicrobial wound dressing as part of a Wound Hygiene protocol to overcome biofilm and wound infection and progress these wounds to healing. <br><br>

Learning Objectives: <br>

Define the microbiology of biofilm and the challenges it presents in wound healing <br>

Explore Wound Hygiene principles and outcomes utilizing an advanced wound dressing with novel antimicrobial technology <br>

Discuss clinical cases incorporating these principles to progress wounds to healing <br>

Sponsored by URGO. <br><br>
Pressure injuries (PIs) are a significant concern in healthcare, often leading to adverse patient outcomes and substantial financial burdens for healthcare institutions. The management and prevention of PIs remain critical components in enhancing patient care and optimizing resource utilization. One promising intervention, pHA (pure hypochlorous acid) has demonstrated efficacy in both the treatment and prevention of pressure injuries. This presentation will explore the various treatment options for pressure injuries, emphasizing the integration of pHA in prevention bundles. Furthermore, we will examine the clinical outcomes associated with pHA, alongside the resulting economic benefits, including cost avoidance and improved patient care.

Artificial Intelligence (AI) is transforming healthcare, offering groundbreaking solutions to long-standing challenges. In wound care, its potential to enhance patient outcomes, streamline operations, and improve efficiency is becoming increasingly clear. However, as AI continues to evolve, it raises critical questions that need to be addressed. This session will explore how AI is not only advancing healthcare but actively shaping its future. Join us for a dynamic, "Comic-Con"-style conversation led by a panel of industry CEOs, as we dive into AI’s powerful role in wound care—examining both its transformative potential and the challenges it presents. Don’t miss this opportunity to engage with thought leaders and gain insights into the future of AI in wound care.

Adequate compression therapy is a major component of the care of patients with leg ulcers due to chronic venous insufficiency. This session with review best practice in determining ideal compression for patients with venous ulcers. For leg ulcer patients with mixed venous and arterial disease, when and how to use compression, and when to avoid it, will be also be discussed.

Recent advances in the study of chronic wounds suggest that these wounds are not merely local tissue problems but are also linked to systemic changes throughout the body. Chronic wounds have been found to correlate with systemic biomarkers, which can be detected in blood, urine, and other fluids, offering new avenues for diagnosis. Additionally, systemic interventions, such as altering the gut microbiome, have demonstrated the potential to impact wound healing and local tissue repair. This session will delve into the complex interplay between chronic wounds and systemic factors, highlighting how these insights can be applied to develop new diagnostic tools and therapeutic approaches.

The Wound Healing Society (WHS), the European Tissue Repair Society (ETRS) and the European Wound Management Association (EWMA) share the common goal of improving wound healing outcomes through research and global dissemination of information. In this collaborative international session, one speaker from each organization will present the latest findings about emerging technologies for reducing scar formation. In addition, this session will stimulate discussion and shape the dialogue focused on this important clinical problem aiming to foster collaborations to advance global research in this critical field.

Scar Prevention Following Burn Injury<br>
Heather Powell, PhD<br><br>
Continuous NPWT Regulates Fibrosis in Diabetic Wound Healing<br>
Adriana Panayi, MD, PhD<br><br>
New Technologies Exploring Dermal Extracellular Matrix<br>
Alexandra Marques, PhD

Wound healing is significantly challenged in patients with heart and peripheral vascular diseases concomitantly due to the interplay of compromised blood flow and systemic health issues. These conditions affect the "pump" (the heart) and the "pipes" (the blood vessels), creating multifaceted barriers to efficient wound repair. This session will review both central (the pump) and peripheral vascular disease as synergistic issues that should be evaluated and treated separately for the best wound healing outcomes, or to understand why would healing is impaired and to document these specific impairments to wound closure.

This session will address the following:<br>
1. Outline current challenges in developing innovative products for non-healing chronic wounds.<br>
2. Discuss the FDA’s collaborative role in wound care innovation<br>
3. Discuss WCCC projects to address the identified challenges<br>

Supported by an educational grant from Kerecis.<br><br>
LEARNING OBJECTIVES<br>
• Investigate the role of clinical evidence in shaping the proposed LCD changes, highlighting how data and research inform policy decisions<br>
• Examine the clinical evidence supporting the use of intact fish skin grafts in wound healing and tissue regeneration<br>
• Summarize key findings from the largest RCT focused on complex DFUs with exposed bone, tendon, or joint capsule, emphasizing the implications for clinical practice

Supported by an educational grant from MTF Biologics.<br><br> Learning objectives:<br> •Recognize the impact of surgical care complications on postoperative infections and identify patient populations at risk for surgical site compromise<br> •Explore the key literature for aseptically processed allografts and placental membranes and their efficacy in managing complex reconstruction and incision management<br> •Examine case-study outcomes utilizing aseptically processed allografts and placental membranes to decrease the risk of surgical site complications and to optimize the results of complex reconstruction<br>

Sponsored by Engineered Tissue Solutions (ETS). <br> <br>

In a prospective, multi-centered randomized controlled trial (RCT) involving 100+ patients, wound care physicians evaluated the impact of Mirragen, a borate-based bioactive glass fiber matrix, in the treatment of diabetic foot ulcers (DFUs). The second RCT on DFUs sponsored by Engineered Tissue Solutions (ETS) further illustrates Mirragen’s ability to facilitate the wound healing process in these challenging wounds. <br> <br>

Join us for our lunch symposium, where top wound care experts will delve into the study’s details and explore why Mirragen is an essential addition to your wound care armamentarium. <br> <br>

Sponsored by LifeNet Health.<br><br>
Discover insights from top experts in reimbursement and clinical practice as they dive into the proposed LCD changes and their potential impact on your practice. Learn how cutting-edge products can empower you to navigate these changes with confidence and stay ahead in delivering exceptional patient care.

Sponsored by Smith+Nephew. <br><br>
Join us for a transformative 1.5-hour session focused on innovative wound care solutions. At the heart of healthcare is the patient, and while many solutions exist for wound management, this session will spotlight the advanced use of Negative Pressure Wound Therapy (NPWT) across the care continuum. Experience a collaborative showcase of NPWT use cases, culminating in a hands-on demonstration designed to revolutionize wound care and enhance patient satisfaction.

Sponsored by Organogenesis. <br> <br>
Join us for an expert panel discussion highlighting real world challenges to wound care. Hear from our expert panel how they navigate these challenges using evidence based solutions, and a patient centric approach. The panel will discuss how the latest RCT and Real-World clinical evidence translates into their day-to-day practices, based on a variety of wound types across sites of care. In addition, the panel will provide insights from research showing how the use of a product bioengineered with living cells, and a fresh amnion allograft retaining living cells and ECM scaffold, can provide healing support and barrier protection, improving the frequency and time to wound closure. <br> <br>

Review the latest research and clinical evidence including Randomized Controlled Trials (RCTs), Real-World Evidence (RWE) and the latest R&D benchtop data. <br> <br>

Review case studies and discuss clinical objectives and observed outcomes. <br> <br>

Sponsored by MIMEDX. <br><br>

Wound care is constantly evolving, and clinicians must adapt to an ever-changing landscape of patient complexities and clinical challenges. In this dynamic symposium, Dr. Paul Kim will discuss how shifting patient demographics, comorbidities, and evolving evidence necessitate updates to traditional treatment pathways for a variety of wounds, including diabetic foot ulcers, venous leg ulcers, and traumatic injuries. Dr. Nicolas Mouawad will present challenging real-world cases, demonstrating how adaptability and innovation are key to successful patient outcomes. Dr. Scott Boynton will round out the discussion by exploring advanced treatment approaches that support clinicians in optimizing wound healing across diverse patient populations.

In the wound care clinic, we don’t just treatment wounds but patients with wounds. Ther are many patient factors that impact wound healing and wound recurrence. The factors include social, psychological as well as other disease states.
Active patient involvement with their wound care can help identify other important factors and can lead to better compliance and better outcomes.

Treatment of venous leg ulcers require appropriate wound treatment as well as treating the venous disease. Standard treatment of the venous disease with an active VLU is multilayer compression. Direct venous intervention is selectively indicated as an adjunct for slowly healing VLUs and also indicated to decrease VLU recurrence. Techniques for direct venous intervention will be discussed.

Studies have shown that various non-medical factors play a significant role in healthcare management. The World Health Organization has defined these social determinants of health that must be addressed to ensure that individuals have the best chance of improving. This session will discuss how these factors can be identified and addressed to improve wound care outcomes.

Venous ulcers are the most prevalent type of chronic lower extremity ulcers, impacting 1% to 3% of the U.S. population. These ulcers significantly affect patients' quality of life while also imposing considerable clinical, economic, and psychosocial burdens on healthcare systems. This underscores the urgent need for a holistic approach to effectively address these challenges and improve patient outcomes. This interactive workshop will feature expert-led discussions and real-life case studies, delving into the underlying pathophysiology, innovative assessment techniques, and effective management strategies for venous leg ulcers (VLUs). Participants will engage in hands-on learning, applying evidence-based treatments such as wound bed preparation, bioburden management, compression technologies, and advanced dressings and therapies. <br><br>

Supported by educational grants from Engineered Tissue Solutions, HARTMANN USA, Inc., LifeNet Health, NATROX® Wound Care, OVIK Health, Smith and Nephew, Solventum, Medical Surgical Business and XSONX, LLC. <br><br> Learning Objectives:<br> •Examine the role of compression therapy in the management of venous leg ulcers, including its mechanisms of action, indications, and evidence-based effectiveness in promoting healing and preventing recurrence<br> •Review the role of dressings in managing exudate from venous leg ulcers, focusing on how different dressing materials and absorbency levels promote optimal moisture balance, prevent maceration, and support wound healing. <br> •Explore the role of debridement in managing VLUs, including methods, techniques, and clinical benefits in promoting wound healing and preventing infection<br> •Evaluate the application of advanced therapies in the treatment of venous leg ulcers, including skin substitutes, negative pressure wound therapy, and topical oxygen therapy and assess their impact on wound healing and patient outcomes. <br>

In this session, young investigators involved in cutting-edge research will compete for the WHS Young Investigator Award. The winner will present his/her work at the ETRS meeting. Oral presentations will feature the top eight abstracts submitted to the WHS by young investigators and the ETRS Young Investigator Award winner.

The SmartTRAK Advanced Wound Care team will present the latest trends and insights related to biologics and skin substitutes, advanced dressings, external devices primarily NPWT and how AI is impacting wound care.<br><br>

Others presenting:<br>
• Elizabeth Anderson<br>
• Kris Flinn<br>
• Jay Merkel<br>
• Lennart Stadler

Treatment of polymicrobial chronic wounds with oral and IV antibiotics can result in anti-microbial resistance, resulting in greater complexity and fewer treatment options. Ideally, chronic wounds could be treated with topical antibiotics tailored to the wound’s microbiome. This session will discuss options for successful topical antibiotic therapy and optimal management often avoiding systemic antibiotics.

If you follow evidence-based therapies for hard to heal venous ulcers (when standard static compression fails), you have seen that intermittent pneumatic compression (IPC) is highly effective. However, because of reimbursement hurdles, IPC therapy is often placed aside. This session will share cases where IPC is the treatment of choice, combining faster healing, decreased pain, increased function and effective reimbursement.

This session aims to explore the critical role of an interprofessional approach in post-acute care and rehabilitation for wound patients by focusing on the multifaceted needs of individuals at risk of and with chronic wounds. This session will highlight the collaborative roles of PTs, OTs, STs, and other healthcare professionals in delivering a comprehensive and effective plan of care. We will delve into the latest research and tech to improve critical aspects of care, such as mobility, positioning, specialty surfaces, contracture management, skin health, gait training, and off-loading. Attendees will discover how the interplay of off-loading, mobility, and exercise are all essential components for healing for most chronic wound types. Further, modality use will be explored as catalyst to activate healing. Lastly, this session will discuss the role of the rehab team in understanding health literacy to influence and improve patient engagement, the primary proxy for a successful plan of care.

It is common knowledge that older patients have slower wound healing. But will their age prevent this from happening? This session explores the impact of aging on wound healing physiology while addressing common management issues such as palliative care, skin failure, and end-of-life care in this population.

This session will discuss and explore the latest advancements in diabetic foot ulcer (DFU) management and neuropathy interventions. Detailing the innovative treatments and strategies aimed at improving outcomes and reducing complications for patients with DFUs due to neuropathic conditions. Gain practical insights on integrating new approaches into clinical practice to enhance wound care efficacy and patient quality of life.

Explore the continuum of care—from home settings to outpatient wound care centers, private practices, and mobile wound care. Discover how integrating lymphedema management across these boundaries enhances patient outcomes. Learn to see the bigger picture, where lymphatic health impacts wound healing.

Due to various limitations with access to care, medicine is evolving into a model with varied sites of service, designed to “meet individuals where they are”. These include mobile health delivery, telehealth and street medicine and patients requiring wound management can present across this care continuum. This session will discuss the unique challenges of various non-traditional settings and provide attendees with practical guidance to optimize treatment outcomes.

Obesity is risk factor for both the development of and non-healing of ulcers. We have come a long way since the only tools for treating obesity were the advice of “you need to eat less and exercise more”. In this session, presenters will discuss newer medical therapies, including GLP1 agonists.

The Bio-Molecular and Physiologic Impact of Stress on Wound Development and Healing<br>
Laura Swoboda, DNP, APNP, FNP-C, FNP-BC, CWOCNAP, WOCNF<br><br>

Advancing Pressure Ulcer Prevention: Innovative Strategy for Skin Protection and Wound Healing<br>
Carlos Zgheib, PhD, MS<br><br>

Characterization of Mechanoresponsive, Pro- Inflammatory Myeloid Cells During Fibrosis from Biomedical Implants<br>
Kellen Chen, PhD<br><br>

Wound healing is a complex biological process influenced by mechanical stress, inflammation, and microenvironmental strain. This session, Battling Stress and Strain in Wound Healing: Creative Approaches to Disparate Challenges, will explore innovative strategies to overcome these barriers. We will have three emerging wound experts discussing how mechanical forces shape healing outcomes, novel biomaterials that mitigate stress-induced damage, and emerging therapeutic approaches that enhance tissue resilience. Attendees will gain insights into the interplay between biomechanics, cellular responses, and translational solutions for improving wound repair.

Sponsored by URGO.<br><br>

Leading guidelines from IWII, WRR, and NPIAP reinforce that “microbial colonies begin to reform within 24 hrs. after debridement” while “slough and necrotic tissue can promote bacterial growth... [and] prevent the formation of granulation tissue.” Research also confirms that “more frequent debridement was associated with improving healing.” Yet, debridement options as standalone debridement remains a challenge. In 2023, the JWC International Consensus Guidelines for Best practices of wound debridement, stated that “approx. 60% of patient’s wounds are not debrided enough” and that using “more than one debridement method may be needed”. This concept is referred to as Integral Debridement which emphasizes combining complementary methods of debridement rather than using standalone approaches. This webinar explores how to adopt Integral debridement into your practice while using UrgoClean Ag. <br> <br>

Objectives for the UrgoClean Ag Innovations Theater: <br> <br>

The 2023 JWC International Consensus Guidelines for Best Practices in Wound Debridement highlight that “approximately 60% of patients' wounds are not debrided enough”. The guidelines recommend using multiple debridement methods, emphasizing the need for an Integral Debridement approach. <br> <br>

In this Innovation Theater, guest speakers will review the new guidelines and demonstrate how they apply Integral Debridement in practice, particularly with UrgoClean Ag. They will highlight the benefits of UrgoClean Ag, present clinical studies and case examples, and discuss its implementation in clinical practice.

The Wound Care Collaborative Community Driving Innovation Summit brings together thought leaders from the WCCC, FDA, and CMS along with key opinion leaders, researchers and representatives from industry, health systems, and payers to evaluate the barriers to wound care innovation and learn how we can overcome those barriers together. The goal is to foster the development and availability of innovative and effective wound-healing therapies to drive advancement and outcomes. <br><br>
Please note this event is by invitation only. Visit this page for more information: https://www.hmpglobalevents.com/sawcspring/driving-innovation-summit

Sponsored by Boehringer Ingelheim. <br><br>

Pyoderma gangrenosum (PG) is a rare, rapidly enlarging, potentially life-threatening ulcerative neutrophilic dermatosis, that can arise from pathergy, including skin trauma, or other triggers. PG is characterized by sterile pustular skin lesions that rapidly evolve into tender skin ulcers. Diagnosis of PG is challenging and misdiagnosis is not uncommon. PG is associated with a substantial burden on quality of life, as it is a debilitating disease with an unpredictable disease course. There are no FDA-approved therapies for PG, and with data lacking, management strategies remain anecdotal. IL-36 is implicated in the pathophysiology of PG and contributes to inflammatory response and progression of disease.

Sponsored by Reprise Biomedical.<br><br>

This session will discuss the use of Miro3D® Wound Matrix and the NEW MiroDry Wound Matrix (Reprise Biomedical, Inc., Minneapolis, MN) which are both three-dimensional porcine collagen matrices that can be press fit into deep, tunneling, and irregular wounds wound beds across a variety of clinical settings. Case reviews and discussions of patients treated with both scaffolds in surgical settings, outpatient wound clinics, physician offices, and home care will demonstrate the benefits of adding these completely unique products into your practice for the management of advanced wounds.

Sponsored by Venture Medical.

While genomics, transcriptomics, proteomics, and metabolomics have long been the foundational pillars of wound healing science, this session will delve into the emerging and less explored "-omics" that reshape the understanding of tissue repair. This includes spatial omics and the molecular influence of stress, ethnicity, and other confounding variables. By examining how these underexplored factors impact the biological processes involved in wound repair, the session aims to uncover the sources of disparities in healing outcomes across different populations. The discussion will highlight how stress, sociocultural factors, and unique biological signatures can contribute to personalized wound care strategies. This session seeks to advance a more holistic and inclusive approach to wound healing that accounts for the broader context of each patient, paving the way for more effective and equitable therapeutic interventions.

Understanding Chronicity of Clinically Presented Wounds Employing Single-Cell Sequencing, Spatial Transcriptomics-Proteomics, and Wound Fluid Metabolomics
Chandan K. Sen, PhD, FNCA <br><br>

Measuring What We Manage: Diagnostics and Theragnostics in the Diabetic Foot
David Armstrong, MD

Supported by an educational grant from Reapplix.<br><br> Learning Objectives:<br> •Review the science and clinical application of an autologous multilayered leukocyte, platelet, and fibrin patch and distinguish from other autologous blood-derived products<br> •Analyze results from a retrospective data analysis on healing outcomes of chronic, hard-to-heal diabetic foot ulcers treated with an autologous multilayered leukocyte, platelet, and fibrin patch in a real-world clinical setting <br> •Examine the impact of an autologous multilayered patch composed of leukocytes, platelets, and fibrin on the perfusion of a chronic wound <br> •Examine the integration of an autologous multilayered leukocyte, platelet, and fibrin patch into a clinic workflow <br>
•Explore illustrative case studies using autologous multilayered leukocyte, platelet, and fibrin patch on chronic wounds<br>

Supported by an educational grant from Smith & Nephew.<br><br> Learning Objectives: <br> • Investigate the potential of collagenase in enhancing the pro-ECM response in chronic wounds through macrophage conversion to a fibroblast-like state <br> • Evaluate the impact of advanced therapies utilizing placental allografts on health outcomes for chronic wounds, supported by recent big data research findings <br> •Examine the mechanism of action and application of single-use NPWT across the continuum<br> •Explore illustrative case-studies leveraging a clean, cover, and close method, integrating advanced therapies for optimal healing outcomes

Supported by an educational grant from Tides Medical.<br><br> Learning Objectives: <br> •Explore the potential of micronized adipose tissue on wound healing <br> •Evaluate the science, research, clinical application and effectiveness of novel 3D-printed adipose tissue matrix grafts for wound healing<br> •Examine case studies that demonstrate the use of low temperature and fibrin method techniques in fat grafting, highlighting their application across various wound types.

Supported by an educational grant from Urgo Medical North America.<br><br> Learning Objectives:<br> •Explore the significance of sharp debridement as a fundamental method for skilled clinicians and how adjunct technologies can enhance or, in some cases, replace sharp debridement in wound care<br> •Examine the well-established benefits of pure hypochlorous acid (pHA) in removing germs and necrotic debris, including its use in instillation therapy to aid wound healing. <br> •Assess how the combination of pHA exposure followed by the application of highly charged fiber dressings can enhance the removal of necrotic tissue, improving wound healing outcomes. <br> •Recognize the underlying science of synergistic technologies and how they work together to facilitate more efficient desloughing and support the debridement process<br>

Oral abstract presentations will feature the highest-scoring abstracts submitted to the WHS.

Total contact casting remains the gold standard for diabetic foot off-loading, but in reality multiple different off-loading strategies are used. How well do these different strategies actually offload? How do each of these options impact a patient’s gait and mobility? How do you decide which is best for YOUR patient? Join us for this informative session to get these questions answered and more!

Plastic & reconstructive surgeons specialize in tissue repair. This session will be led by plastic surgeons who will share their approach to complex wounds which may include surgical reconstructive options for closure and non-surgical options. Both options may include advanced wound therapies traditionally utilized for secondary healing that may also be used to optimized reconstructive surgical options.

This presentation will review and discuss the current UHMS approved indications available to practitioners to prescribe for appropriate patients. Discussion will also include all the new indications that were recently approved. If you want to know which new indication was recently approved by the UHMS come and attend this session. The session will review new evidence associated with all UHMS approved indications.

Patients in need of optimal wound care is growing, which has been shown to reduce amputations and hospital/ER visits & readmissions, while increasing rates of wound healing. However, there are obstacles to proving the value to hospitals & administrations in its cost effectiveness, resulting in closure or lack of interest in wound care centers. We aim to have a factually driven conversation in a multi-disciplinary format with vital stakeholders as to the value, profitability, and critical need for wound care centers and how to address this dilemma.

Developed in collaboration with the Alliance for Wound Care Stakeholders.

Oral abstract presentations will feature the highest-scoring abstracts submitted to the WHS.

Supported by an educational grant from CHIESI USA, Inc.<br><br> Learning objectives:<br> •Examine the genetic mutations and underlying pathophysiology of Junctional Epidermolysis Bullosa (JEB) and Dystrophic Epidermolysis Bullosa (DEB) and recognize their clinical manifestations<br> •Explain the standard management practices for EB including wound care, routine extracutaneous monitoring, and coordination with a multidisciplinary team to address the diverse needs of the patient<br> •Evaluate current FDA-approved treatments for Epidermolysis Bullosa (EB) as well as emerging therapies, understanding their mechanisms of action<br>

This session focuses on the more common surgical procedures utilized for the surgical treatment of diabetic foot ulcers. This includes a discussion of osseous and soft tissue procedures. There are surgical options to cover or close the soft tissue envelope as well as to address the underlying biomechanical faults that contribute to the development and chronicity of the diabetic foot ulcer. The published outcomes for some of these procedures will also be reviewed.

This session will discuss the pros and cons of HBOT verses topical oxygen treatment (TOT) in wound healing. The speakers will debate how and when oxygen delivery systems (HBOT and TOT) have the potential to improve wound healing. They will discuss the evidence and science that suggests that TOT may be more beneficial in superficial wounds as compared to HBOT that may be appropriate for deeper and more complicated wounds.

Wound/ulcer management professionals are often misled by inaccurate coding and compliance information which leads to payment that results in audits, repayments, fines, etc. This session will provide clear guidance to prevent the top 10 wound/ulcer management reimbursement mistakes, to get paid fairly, and to keep your payment after audits.

Developed in collaboration with the Alliance for Wound Care Stakeholders.

This session will highlight six exciting projects in the NIDDK Diabetic Foot Consortium for biomarkers predictive of diabetic foot ulcer healing. A panel discussion will follow short presentations on bacterial biomarkers that analyze the transcriptome (Dr. Lindsay Kalan) and metagenome (Dr. Brian Schmidt) of the wound microbiome; wound bed biomarkers that measure its metabolites (Dr. Sashwati Roy) and inflammatory state of macrophages (Dr. Kara Spiller); and systemic biomarkers that measure serum proteins (Dr. Monika Niewczas) and urine microRNAs (Dr. Rivka Stone).

Supported by an educational grant from Urgo Foundation. <br><br>
In kind support provided by LifeNet Health, MolecuLight and Solventum, Medical Surgical Business. <br><br>
LEARNING OBJECTIVES<br><br>
• Explain the drivers of wound infection today<br>
• Determine if there are gradations of contamination that be agreed upon and differentiate modes of treatment for wounds contaminated at various levels; what role, if any, does biofilm play in the issues faced?<br>
• Categorize the levels of microbes in the wound<br>
• Assess current techniques, in the in-patient and out-patient settings, to determine levels of contamination and identify which method to use and when<br>
• Outline new and emerging technologies to determine levels of contamination and infection in the wound<br>
• Determine the relationship between slough removal and infection control?<br>
• Explain the role of silver, Iodine, acetic acid and systemic antibiotic in the management of infection<br>
• Examine new and emerging technologies for slough dermal removal including a novel hypochlorous acid, charged fiber<br>
• Examine findings from the recent IWII cleansing guidelines<br>
• Explore illustrative case-studies on wound infection management and apply current strategies<br>

This session will give attendees the ability to interact directly with authors over their research. Selected poster presenters will give a 3–5-minute summary of their poster, followed by Q&A from the audience. The interaction is meant to be collegial, not critical, with the goal of attendees learning from the poster presenters experience and project.

This session will review ways to augment the care for patients with and at risk for wound by using novel wearables and sensors that have been approved, are in clinical investigation or have been reported in the recent literature. Examples include new approaches for common and less common wounds. Expert speakers will also review the array of potential new options, how to utilize them and what the future holds as we strive to will help improve care for patients.

This session will be a case-based approach to the various approaches to correct diagnosis of wounds and skin changes from pressure injuries including distinguishing mimickers of pressure injuries from other common and uncommon causes of skin and wounds.. The latest options in the management and prevention of pressure injuries will also be provided.

The updated Medicare Local Coverage Determination (LCD) policy on Skin Substitute Grafts and Cellular and Tissue-Based Products (CTPs) introduces significant changes for wound care professionals treating diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs). This lecture will provide an in-depth overview of the revised policy, focusing on the expanded indications for use over exposed muscle, tendon, and bone, extended therapy duration from 12 to 16 weeks, and the increased application limit from 4 to 8 per episode of care. The session will highlight key documentation requirements, ICD-10 code updates, and the proper use of the KX modifier to attest to medical necessity for additional applications. Practical strategies for integrating these changes into clinical workflows, ensuring compliance, and optimizing patient outcomes will be discussed. Attendees will gain actionable insights into policy implementation, supported by real-world evidence and case studies. This session will empower wound care professionals to navigate the new policy and enhance patient care outcomes.

This session will highlight the work of individuals that have recently received awards for their work, including the WHS Lifetime Achievement Award winner and several junior faculty members that have been recipients of research-related awards.<br><br>

Rejected. Cancelled. Unstoppable: A Journey of Purpose and Service in Wound Healing Research<br>
WHS Distinguished Service Award Winner: Marjana Tomic-Canic, PhD<br><br>

Network-Based Spatio-Temporal Analysis Of Wound Healing<br>
WHS Research Grant Recipient: Mateusz S. Wietecha, DMD, PhD<br><br>

Advancing Research on Diabetic Foot Ulcers – NIDDK and the Diabetic Foot Consortium <br>
WHS Distinguished Recognition for the Public Service in Advancing Wound Healing Research: Teresa Jones, MD<br><br>

Sponsored by Solventum. <br> <br>

New product innovations are introduced every year! It can be overwhelming to continually elucidate the rapidly evolving medical advancements in the tech industry. When recognizing a game-changing therapy, what is the most effective way to integrate it into a health care system or medical practice? <br><br>

This program will empower learners to become advocates of new technologies. The learner will: <br>

-Examine how clinical experts have introduced advanced wound therapies and dressings into their practice <br>

-Understand the key steps and stakeholders involved in getting a product approved within a medical system <br>

-Understand how data collection/reporting and protocol development can help implement institutional changes <br>

-Recognize the power of evidence-based medicine by staying in-tune with the latest research <br>

-Observe common wound care challenges and solutions through patient case presentations <br>

-Engage in Q&A about best practices across care settings <br>

This session will highlight the highest-scoring abstracts selected for poster presentations. Eight short 'rapid-fire' poster talks will be featured. Presenters will have one slide and two minutes to summarize novel research findings, then one minute to answer questions. This session will immediately precede the poster gala, where all poster presenters will be available to discuss their research.

This session will feature first-to-podium presentations of practice-changing research from the leading minds in the field. The best posters in each category will also be recognized and awarded. Finally, the annual Evonne Fowler Founder’s Award will honor an individual whose tireless service has promoted the excellence of our conference and furthered our goal of creating a collaborative community.

Sponsored by Solventum. <br><br>

As new medical treatments and therapies are introduced into market, the task of choosing the best option can be daunting. It’s important to approach wound management with a thorough understanding of the potential benefits and risks. This program will offer tools to understand when to use Advanced Wound Dressings and NPWT technologies. The learner will: <br><br>

-Understand treatment algorithms through careful therapy selection to achieve optimal healing outcomes <br>

-Examine decision-making and product selection processes by re-evaluating wound progression at every stage of care <br>

-Identify patient/wound criteria through a case-based discussion about various “hard-to-heal” wounds <br>

-Observe tips and pearls for successful applications <br>

-Become an advocate for new therapies within your practice <br>

-Engage in Q&A about best practices across care settings <br>

Sponsored by AOTI; DeRoyal; Hartmann; ProMed Billing Solutions. <br><br>

Sponsored by MediWound Ltd. <br><br>

EscharEx® is a novel biological drug composed of a concentrate of proteolytic enzymes enriched in bromelain, derived from the stem of the pineapple plant. Its unique enzymatic composition enables fast and effective debridement of wounds containing various forms of denatured proteins and non-viable tissue. <br><br>

The same active ingredient is also used in NexoBrid®, a medicinal product approved in the EU, US, and Japan for the removal of eschar in adult and pediatric patients with deep partial- and full-thickness burns. <br><br>

In vitro and preclinical studies have provided insights into the multimodal mechanism of action of EscharEx, supporting its therapeutic potential across a range of wound types. Phase II randomized controlled trials in venous leg ulcers (VLU), diabetic foot ulcers (DFU), and traumatic wounds have demonstrated EscharEx’s consistent efficacy in wound debridement, promotion of granulation tissue, and reduction of bioburden and biofilm. <br><br>

These promising results have led to the launch of a global Phase III study - the VALUE trial, designed to evaluate the efficacy of EscharEx in wound bed preparation and facilitation of closure in patients with VLU. A Phase II/III study in DFU is currently in development. <br><br>

This breakfast symposium will highlight EscharEx’s unique mechanism of action, review key findings from previous clinical trials, share specific case studies in VLU and DFU, and provide updates on the design and progress of ongoing and planned clinical trials.

This session will explore how Artificial Intelligence (AI)'s changing wound care by looking at the advanced technologies powered by AI that are transforming how we diagnose wounds and predict outcomes for healing while also improving treatment approaches. We have two eminent speakers who will talk about the ways in which machine learning algorithms and predictive models, as well as AI-supported decision-making systems, are improving wound evaluation processes and leading to better results for patients. This session will also showcase real-world applications of AI in capturing images of wounds, examining risks, and automatically analyzing data to underline the significant role of AI in shaping the future of wound care. <br><br>

Next-Gen Biopsy-Free Wound Histopathology<br>
Kyle Quinn, PhD<br>

Sponsored by Organogenesis. <br><br>

Join us as we explore how the integration of scientific research and evidence-based practice is transforming wound care and how it can support efforts to heal patients’ wounds. This program will highlight how a data-driven approach to wound care can enhance clinical decision-making while addressing bioburden and biofilm, and supporting wound closure. Following the program, bridge the gap between theory and practice, by translating your knowledge into real-world experience through an interactive, hands-on wet lab. <br><br>

Learning objectives: <br><br>

-Understand how the latest scientific evidence and patient-centered approaches are transforming the wound care landscape <br><br>

-Hands-on product application in a wet lab environment with the Organogenesis portfolio to translate scientific knowledge into actionable skills

Sponsored by Integra LifeSciences. <br><br>

Jeffrey Jensen, DPM<br>
Dean of Podiatric Medicine Midwestern University Glendale, AZ<br>
Director, TCC Integra Lifesciences and Inventor of the TCC-EZ® and MedE-Kast® Total Contact Casting systems<br><br>

Robert Klein, DPM, FACFAS, CWS: FFPM RCPS (Glasgow) Division Chair, Wound Care Prisma Health<br>
Adjunct Associate Professor, Clemson University, Department of Bioengineering<br>

Sponsored by URGO. <br><br>
This workshop will focus on providing clinicians with actionable tips, techniques, and insights for effectively applying compression therapy to difficult-to-treat legs. While clinicians may grasp the theoretical aspects of compression kits during training, applying this knowledge to complex, real-world cases can be a significant challenge. This session aims to bridge that gap. <br><br>

Key Features of the Session: <br><br>

Real-World Case Studies: Clinicians will engage with actual case scenarios that present unique challenges when applying compression therapy. <br>

Practical Tips and Tricks: Gain insight into proven methods and techniques for improving the success of compression therapy, especially in tough cases. <br>

Interactive Learning: The session will include interactive elements like live Q&A, trivia, and participant-driven discussion to reinforce key concepts and foster engagement. <br>

Tribal Knowledge: We'll highlight the most effective tips and tricks from experienced clinicians, providing real-world solutions that participants can apply immediately in their practice. <br>

Oral presentations will feature the highest-scoring abstracts submitted to the WHS

This session will feature podium presentations from four of the highest scoring abstracts submitted to SAWC. Each presenting author will have up to 12 minutes to present key results of their research, followed by Q&A time with the audience, moderated by a member of the SAWC Oral Abstract Review Committee.

Hospitalized neonates are at a higher risk of both medical adhesive removal injuries as well as hospital acquired device related pressure injuries than their pediatric and adult counterparts, largely due to their very underdeveloped skin. This session will present a standardized evidence-based guideline developed offering a variety of usable options for clinicians caring for this vulnerable population of patients.

For 14 years, Wound Scene Investigation was an SAWC participant favorite and Dr. Greg Schultz was a key part of the panel, taking clinical issues from the “bedside to the bench” and back. Join the WSI panel as we revisit and update past cases, honoring a small part of Dr. Schultz’ life’s work.

Each year, approximately 100,000 people undergo ostomy surgery in the United States. Up to 1 million people live with an ostomy, which is about 1 in 500 Americans. With early-onset cancer and the increased incidence of inflammatory bowel disease, more young Americans are undergoing ostomy surgery. Whether an ostomy is temporary or permanent, persons with ostomies need education on available resources in the community. This presentation aims to equip attendees with proficiency in the prevention and management of common ostomy-related complication seen in home and outpatient settings. Attendees will have access to community resources with a focus on care coordination to improve the quality of life for persons with ostomies.

Physical Therapy has played a role in wound management for decades beginning with the use of biophysical technologies to treat individuals with burns, pressure injury and dermatological conditions. This presentation discusses the presenter's journey in research and practice that has helped to shape modern day practice of physical therapists as members of the multidisciplinary wound care team. It concludes with an emphasis on collaborative practice.

Exercise and activity are vital for all of our well-being. As humans, we are designed to move. This session will provide ideas for incorporating exercise prescription into your plan of care for patients with wounds.

Adipocytes through their release of bioactive products, lipids, hormones and adipokines, are viewed as a critical regulator of wound healing. Leptin, an adipocyte-derived hormone, plays an important role in the wound healing process. Additionally, human adipocyte-derived stem cells reduce inflammation, induce angiogenesis, and promote fibroblast and keratinocyte growth. The clinical use of fat grafting to restore volume loss due to trauma, ablative surgery, aging or congenital defects has been expanded to more regenerative-based approaches such as improving wound healing or aged skin as well as treating scars.

Wounds are often associated with pain, which adversely affects a patient’s quality of life. Simultaneously, we are in the midst of an opioid epidemic. In this session, presenters will discuss both pharmacologic and non-pharmacologic therapies will allow the wound healer to better care for their patients suffering with pain.

For some of our patients access to costly dressings and topical medications for ulcer care is not possible. In other cases, there may be a delay in obtaining prescribed dressings and medications, thus a temporary substitute may be necessary. This session focuses on relatively inexpensive, easily accessible alternatives available to them for home care. This includes items such as dilute vinegar, and other anti-infective agents, other natural anti-inflammatory, and prohealing agents.

Reimbursement for Cellular, Acellular, and Matrix Products (CAMPs) has changed as of 2024, with strict criteria for their use. This session will present what all providers should know about changes in reimbursement rules for the use of CAMPs in the care of patients with chronic wounds unresponsive to optimal standard care.

Developed in collaboration with the Alliance for Wound Care Stakeholders.

Angiosome anatomy refers to the specific vascular territories supplied by distinct arteries and veins, playing a critical role in the management and healing of wounds. Understanding angiosome anatomy is vital to clinicians, particularly in the fields of vascular surgery and wound management. Knowledge of these distinct vascular territories aids in understanding local as well as downstream skin and underlying tissue damage patterns. Knowledge of angiosome vascular anatomy and dermal vascular patterns facilitates the identification of compromised blood flow regions, guiding revascularization procedures and enhancing the outcomes for wound healing. This knowledge is essential in creating care plans for interventions and for understanding tissue death patterns when blood supply cannot be reestablished due to clinical complications of the patient, such as the inability to revascularize arteries in the lower extremity.

HMP Education, LLC has designated an unrestricted educational grant from MIMOSA Diagnostics for support of this session. <br><br>

Near-infrared spectroscopy (NIRS) has emerged as a valuable tool in wound care, particularly for assessing microcirculation in patients with chronic wounds. NIRS operates by measuring the absorption of near-infrared light by oxygenated and deoxygenated hemoglobin, providing real-time data on tissue oxygenation and perfusion. This Rapid Fire session will look at how this non-invasive technique offers significant advantages over traditional methods such as the ankle-brachial index (ABI), which primarily evaluates macrocirculation and may yield less accurate results in patients with microvascular disease. By offering detailed insights into microcirculatory status, NIRS can help guide and enhance clinical decision-making, leading to more precise interventions and improved wound healing outcomes. Hard-to-heal Lower extremity cases will be discussed.

The use of systemic and topical medication in conditions for which there is not FDA approval can be a daunting proposition. This session will provide insights and guidance in the off-label use of medications in the wound care setting.

This session aims to provide healthcare professionals with a comprehensive understanding of the hands-on enteric fistulas care techniques crucial for successful management. Through a series of photographic cases, this session will provide a detailed, step-by-step framework for effectively addressing the complexities associated with enteric fistulas.

What are biofilms and do they impact wound healing? And if they do, how can they be reduced or eliminated? This session will review up to date information on the impact of biofilms in chronic wounds and discuss how clinicians can address them.

A growing problem, this session will explore approaches to managing the patients and the most common skin and soft tissue challenges following purposeful injection of street drugs.

In many communities the wait times for patients to see a Dermatologist are unacceptably long, driving an increased number of referrals to wound care practitioners as “the next best thing.” This session will be in a case-based format, shared by a wound care practitioner and a Dermatologist, and will focus on dermatologic conditions presenting as wounds.

The SAWC Difference Makers are a group of inspiring individuals who actively seek to advance the practice of wound care for their patients, values being a part of an interdisciplinary care team, and most importantly, disseminates their wound care knowledge with colleagues. Selected by leaders within the Wound Healing Society, the American Podiatric Medical Association (APMA), and the APTA’s Academy of Clinical Electrophysiology & Wound Management - Special Interest Group (ACEWM-SIG), the SAWC Difference Makers Scholarship Recipients have positively impacted their community and will share their professional practice achievements and professional practice goals in this inspiring session.<br><br>

Academy of the American Physical Therapy Association (APTA)<b><br>
Presentation of Award by: TBD<br>
Award Recipient: Diana M. Garcia, PT, DPT<br><br>

American Podiatric Medical Association (APMA))<b><br>
Presentation of Award by: Leslie Campbell, DPM<br>
Award Recipient: Christopher Girgis, DPM<br><br><br>

WHS (Wound Healing Society))<b><br>
Presentation of Awards by: Dr. Sundeep Keswani<br>
Award Recipients: <br>

-SAWC Physician: Brian Schmidt, DPM<br>

-SAWC Research Scholar: Jacob Ancira<br>

-SAWC Nurse Scholar: Linda Benskin, PhD, RN, SRN (Ghana), CWCN <br>

The cost of treating wounds in the US exceeds $45 billion yet there is still a lack of very basic wound education in the healthcare curriculum. The lack of specialized wound care expertise for the front-line, boots on the ground clinicians translates into challenging circumstances for patients to get appropriate, timely wound care and preventive support. In this panel discussion, key luminaries in the field will discuss how they became inspired to devote their careers to wound healing and are now using their expertise to train the next generation. We will identify the gaps and opportunities that exist to incorporate comprehensive wound care education into various healthcare disciplines, including nursing, medicine, podiatry, and physical therapy. Featuring expert insights on developing effective educational curricula, the session will demonstrate how you can join forces to integrate wound care education into existing professional school training programs while fostering the development of highly skilled wound care professionals for generations to come.

This session will delve into the adaptive wound care needs that are tailored specifically for athletes with disabilities, where unique challenges and innovative solutions converge. This session will explore specialized strategies designed to optimize healing and performance for this diverse and dynamic population. The speakers will showcase real-world cases showcasing effective approaches in managing wounds to support athletes with disabilities in achieving their athletic goals.

Clinicians often encounter wounds that despite providing appropriate local and supportive care do not respond or may even get worse. This session will focus on those lower extremity wounds that may have begun as a minor trauma, may be masquerading as a venous or other type of wound, but are not responding to seemingly appropriate care. Assessment tips, biopsy/histology suggestions and potential management options will be discussed.

The differential diagnosis of a patient presenting with a “red leg” varies widely from the benign to life threatening. Determining the correct diagnosis impacts management and outcomes. Attend this session to learn about the various shades of red on the work-up and treatment of the patient.

Electric energy, sound energy, mechanical energy – how do introduction of these modalities into a patient’s wound impact healing? This session will explore modalities available for wound healing and discuss available evidence for their use.

The use of negative pressure wound therapy for large tissue defects has been well established. More recently the role of NPWT has been expanding: it is being used in treating fistulas in the GI tract; prevention of surgical site infections and wound dehiscence in freshly closed surgical wounds, an indication that is expanding and still being evaluated; together with irrigation, use as adjunct in treatment of freshly opened and drained wound infections, which previously was viewed as a contraindication.